ACCESS BIOTECHNOLOGY
Access Biotechnology is the life science investment arm of Access Industries. They invest in transformative therapies for conditions with high unmet needs and that have the potential to meaningfully impact human health. They invest in both private and public biopharma companies across therapeutic areas, modalities, and development stages – from discovery-stage technology platforms to late-stage clinical programs. The company is based in New York.
ACCESS BIOTECHNOLOGY
Social Links:
Industry:
Biopharma Biotechnology Health Care Life Science
Founded:
1986-01-01
Status:
Active
Contact:
(212) 247-6400
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Apache Sitelinks Search Box Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins PHP
Similar Organizations
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Penn Medicine Co-Investment Program
Penn Medicine Co-Investment Program makes investments in faculty-driven cell therapy, gene therapy, and connected health companies
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-10 | Disc Medicine | Access Biotechnology investment in Venture Round - Disc Medicine | N/A |
| 2022-07-12 | Areteia Therapeutics | Access Biotechnology investment in Series A - Areteia Therapeutics | 350 M USD |
| 2022-06-02 | Upstream Bio | Access Biotechnology investment in Series A - Upstream Bio | 200 M USD |
| 2021-12-01 | Curie Therapeutics | Access Biotechnology investment in Series A - Curie Therapeutics | 75 M USD |
| 2021-11-15 | Recludix Pharma | Access Biotechnology investment in Series A - Recludix Pharma | 60 M USD |
| 2021-09-02 | Disc Medicine | Access Biotechnology investment in Series B - Disc Medicine | 90 M USD |
| 2021-07-13 | Nimbus Therapeutics | Access Biotechnology investment in Venture Round - Nimbus Therapeutics | 105 M USD |
| 2021-05-24 | Eliem Therapeutics | Access Biotechnology investment in Series B - Eliem Therapeutics | 60 M USD |
| 2021-03-25 | Eliem Therapeutics | Access Biotechnology investment in Series A - Eliem Therapeutics | 80 M USD |
| 2021-03-01 | DTx Pharma | Access Biotechnology investment in Series B - DTx Pharma | 100 M USD |
More informations about "Access Biotechnology"
Access Biotechnology (life science investment arm of Access …
Oct 29, 2019 Access Biotechnology is the biopharma investment arm of Access Industries, a U.S.-based private holding company and investment firm. Access invests in private and public …See details»
Access Biotechnology - Crunchbase Investor Profile
Access Biotechnology is the life science investment arm of Access Industries. They invest in transformative therapies for conditions with high unmet needs and that have the potential to meaningfully impact human health. They invest in …See details»
Access Biotechnology - CB Insights
May 2, 2024 About Access Biotechnology Access Biotechnology is the biopharma investment arm of Access Industries, a U.S.-based private holding company and investment firm. Access …See details»
Access Biotechnology - Investments, Portfolio & Company Exits
Access Biotechnology has made 8 diversity investments. Their most recent diversity investment was on Jul 30, 2024 , when Day One Biopharmaceuticals raised obfuscatedSee details»
Access Biotechnology investment portfolio - PitchBook
Access Biotechnology's latest investment was on 01-Aug-2024 in Day One Biopharmaceuticals, a company within the Pharmaceuticals industry. Data Transparency. Meet our data hygiene team. Discover how our experts ensure …See details»
Access Biotechnology - Investor Profile, Portfolio & Team - Tracxn
6 days ago Access Biotechnology is a venture capital firm founded in 1986.It is primarily based out of New York City, United States. As of Jan 2025, Access Biotechnology is an active …See details»
Access Biotechnology Inc - Company Profile and News
Access Biotechnology Inc operates as an investment firm. The Company invests in both private and public biopharma companies across therapeutic areas, modalities, and development …See details»
Access Biotechnology - raizer.app
Access Biotechnology is an investment arm of Access Industries that focuses on private and public biopharma companies. Learn which startups Access Biotechnology invests in, number …See details»
Access Biotechnology | PrivSource
Access Biotechnology, established in 2019, invests in biopharma companies developing transformative therapies for conditions with high unmet needs. With a broad investment scope …See details»
Access Biotechnology (investor) - Nordic 9
Access Biotechnology (investor). Access Biotechnology is an investment arm of Access Industries that focuses on private and public biopharma companies across therapeutic areas, modalities, …See details»
Access Biotechnology - Contacts, Employees, Board Members
Access Biotechnology has 4 current employee profiles, including Principal Dan Becker. Dan Becker Principal. Christine Borowski Senior Associate. Liam Ratcliffe Head of Biotechnology. …See details»
Access Bio – A TRUSTED PARTNER IN GLOBAL HEALTH
Access Bio’s mission is to improve the lives and well-being of people around the world. Through the development of in vitro diagnostics technology, Access Bio has successfully …See details»
GRO Biosciences Closes $60M Series B Financing Co-Led by Atlas …
Jul 19, 2024 Access Biotechnology is the biopharma investment arm of Access Industries, a U.S.-based private holding company and investment firm. Access invests in private and public …See details»
Biotechnology Innovation Organization | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... to patients with serious …See details»
Access Biotechnology - teaserclub.com
Access Biotechnology is the life science investment arm of Access Industries, established in 2019 and located in New York. The firm focuses on investing in transformative therapies aimed at …See details»
New survey: U.S. biotechs warn tariffs could impede access to …
1 day ago WASHINGTON (March 26, 2025) -- Today, the Biotechnology Innovation Organization (BIO) released results from a membership survey that underscores the significant, global …See details»
Drugmakers sound alarm on possible Trump tariff impacts
17 hours ago As President Donald Trump renewed his threat of potential pharmaceutical tariffs this week, trade group the Biotechnology Innovation Organization (BIO) is warning of the …See details»
Tariffs Would Impede Access to Affordable Drugs, Industry Warns
1 day ago More than nine in 10 pharma companies believe that President Donald Trump’s proposed tariffs would pose a heavy burden on the industry, according to the results of a …See details»
Access Biotechnology - Tech Stack, Apps, Patents & Trademarks
Access Biotechnology is actively using the technology Common Crawl for its website, according to BuiltWith. UNLOCK PREMIUM DATA WITH DATABOOST IT Spend by Aberdeen. Edit IT …See details»
Federal government announces support for cutting-edge, AI- and …
5 days ago “Patient access to cell-based cancer therapies has been hindered by high manufacturing costs and complex cold-chain logistics. ... OmniaBio Inc. is a technology …See details»